JP2023540137A5 - - Google Patents
Info
- Publication number
- JP2023540137A5 JP2023540137A5 JP2023515559A JP2023515559A JP2023540137A5 JP 2023540137 A5 JP2023540137 A5 JP 2023540137A5 JP 2023515559 A JP2023515559 A JP 2023515559A JP 2023515559 A JP2023515559 A JP 2023515559A JP 2023540137 A5 JP2023540137 A5 JP 2023540137A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- approximately
- pharmaceutically acceptable
- hydroxybenzonitrile
- difluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025269820A JP2026067866A (ja) | 2020-09-09 | 2025-12-19 | ソマトスタチン調節因子の製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063076024P | 2020-09-09 | 2020-09-09 | |
| US63/076,024 | 2020-09-09 | ||
| PCT/US2021/049282 WO2022055880A1 (en) | 2020-09-09 | 2021-09-07 | Formulations of a somatostatin modulator |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025269820A Division JP2026067866A (ja) | 2020-09-09 | 2025-12-19 | ソマトスタチン調節因子の製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540137A JP2023540137A (ja) | 2023-09-21 |
| JP2023540137A5 true JP2023540137A5 (https=) | 2024-09-17 |
| JP7796115B2 JP7796115B2 (ja) | 2026-01-08 |
Family
ID=78078387
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515559A Active JP7796115B2 (ja) | 2020-09-09 | 2021-09-07 | ソマトスタチン調節因子の製剤 |
| JP2025269820A Pending JP2026067866A (ja) | 2020-09-09 | 2025-12-19 | ソマトスタチン調節因子の製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025269820A Pending JP2026067866A (ja) | 2020-09-09 | 2025-12-19 | ソマトスタチン調節因子の製剤 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US11266641B1 (https=) |
| EP (2) | EP4210700B1 (https=) |
| JP (2) | JP7796115B2 (https=) |
| KR (1) | KR20230066379A (https=) |
| CN (2) | CN116456968B (https=) |
| AR (1) | AR123453A1 (https=) |
| AU (1) | AU2021341936A1 (https=) |
| CA (1) | CA3191084A1 (https=) |
| CL (1) | CL2023000627A1 (https=) |
| CO (1) | CO2023004346A2 (https=) |
| DK (1) | DK4210700T3 (https=) |
| ES (1) | ES3040117T3 (https=) |
| FI (1) | FI4210700T3 (https=) |
| HR (1) | HRP20250995T1 (https=) |
| IL (1) | IL301038A (https=) |
| LT (1) | LT4210700T (https=) |
| MA (1) | MA66139B1 (https=) |
| MD (1) | MD4210700T2 (https=) |
| MX (1) | MX2023002761A (https=) |
| PE (1) | PE20231850A1 (https=) |
| PL (1) | PL4210700T3 (https=) |
| PT (1) | PT4210700T (https=) |
| RS (1) | RS67208B1 (https=) |
| SI (1) | SI4210700T1 (https=) |
| SM (1) | SMT202500315T1 (https=) |
| WO (1) | WO2022055880A1 (https=) |
| ZA (1) | ZA202303250B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL264178B2 (en) | 2016-07-14 | 2024-05-01 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| CA3191084A1 (en) | 2020-09-09 | 2022-03-17 | Gerald Burke | Formulations of a somatostatin modulator |
| WO2023137018A1 (en) * | 2022-01-11 | 2023-07-20 | Crinetics Pharmaceuticals, Inc. | Uses of a somatostatin modulator for the treatment of carcinoid syndrome |
| PE20260136A1 (es) * | 2022-05-11 | 2026-01-21 | Lilly Co Eli | Composiciones farmaceuticas de glp1 |
| CN115919866A (zh) * | 2022-12-07 | 2023-04-07 | 深圳海王医药科技研究院有限公司 | 特泊替尼固体分散体及其制备方法 |
| KR20250162795A (ko) | 2023-03-28 | 2025-11-19 | 크리네틱스 파마슈티칼스, 인크. | 간 기능장애가 있는 환자에게 팔투소틴을 투여하기 위한 조성물 및 방법 |
| JP7797570B2 (ja) | 2023-05-23 | 2026-01-13 | ユルチョン・ケミカル・カンパニー・リミテッド | セルパウチ用フィルム及びその保管方法 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| CA2468159A1 (en) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 4-aminoquinoline compounds |
| WO2003066055A1 (en) | 2002-02-04 | 2003-08-14 | F. Hoffmann-La Roche Ag | Quinoline derivatives as npy antagonists |
| US7767817B2 (en) | 2003-09-05 | 2010-08-03 | Binghe Wang | Water soluble boronic acid fluorescent reporter compounds and methods of use thereof |
| JP2008506695A (ja) | 2004-07-13 | 2008-03-06 | グラクソ グループ リミテッド | 抗細菌剤 |
| US20060183763A1 (en) | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
| US7563821B2 (en) | 2005-12-05 | 2009-07-21 | Xenoport, Inc. | Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| WO2007098214A1 (en) | 2006-02-21 | 2007-08-30 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| WO2007103554A1 (en) | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| AU2007309708A1 (en) | 2006-03-13 | 2008-05-02 | Merck Sharp & Dohme Corp. | Somatostatin agonists |
| US8871728B2 (en) | 2007-06-29 | 2014-10-28 | Georgia Tech Research Corporation | Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof |
| HRP20180328T1 (hr) * | 2008-08-13 | 2018-04-20 | Vertex Pharmaceuticals Inc. | FARMACEUTSKI PRIPRAVAK N-[2,4-bis(1,1-DIMETILETIL)-5-HIDROKSIFENIL]-1,4-DIHIDRO-4-OKSOKINOLIN-3-KARBOKSAMIDA I NJEGOVO DAVANJE |
| US20100256184A1 (en) * | 2008-08-13 | 2010-10-07 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US20100074949A1 (en) * | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| JP5564045B2 (ja) | 2008-09-02 | 2014-07-30 | ノバルティス アーゲー | 二環式キナーゼ阻害剤 |
| GB0818241D0 (en) | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| CA2806332C (en) | 2010-07-30 | 2017-11-14 | Oncotherapy Science, Inc. | Quinoline derivatives and melk inhibitors containing the same |
| RU2013113627A (ru) * | 2010-08-27 | 2014-10-10 | Вертекс Фармасьютикалз Инкорпорейтед | Фармацевтическая композиция и ее введения |
| US9328075B2 (en) | 2011-05-05 | 2016-05-03 | St. Jude Children's Research Hospital | Pyrimidinone compounds and methods for treating influenza |
| RU2637936C2 (ru) | 2011-05-23 | 2017-12-08 | Элан Фармасьютикалз, Инк. | Ингибиторы активности киназы lrrk2 |
| WO2012163354A1 (en) | 2011-05-31 | 2012-12-06 | Linak A/S | Actuator |
| US8871756B2 (en) | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
| DE102011113749A1 (de) | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole |
| US20140228417A1 (en) | 2011-10-05 | 2014-08-14 | Mapi Pharma Ltd. | Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids |
| WO2014007228A1 (ja) | 2012-07-03 | 2014-01-09 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
| KR20150039832A (ko) | 2012-08-06 | 2015-04-13 | 사피라 파르마슈티칼즈 게엠베하 | 디하이드록시피리미딘 탄산 유도체 및 바이러스성 질환의 치료, 개선 또는 예방에서의 이의 용도 |
| JP6404217B2 (ja) | 2012-09-11 | 2018-10-10 | メディベイション プロステイト セラピューティクス エルエルシー | エンザルタミドの製剤 |
| CN105073729A (zh) | 2012-10-16 | 2015-11-18 | 詹森药业有限公司 | RORγt的苯基连接的喹啉基调节剂 |
| WO2014114575A1 (en) | 2013-01-22 | 2014-07-31 | F. Hoffmann-La Roche Ag | Pharmaceutical composition with improved bioavailability |
| US10647664B2 (en) | 2013-08-16 | 2020-05-12 | Duke University | Substituted hydroxamic acid compounds |
| US9643951B2 (en) | 2013-09-30 | 2017-05-09 | Ono Pharmaceutical Co., Ltd. | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| JPWO2015146929A1 (ja) | 2014-03-24 | 2017-04-13 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2016049568A1 (en) | 2014-09-25 | 2016-03-31 | Araxes Pharma Llc | Methods and compositions for inhibition of ras |
| AU2015360485B2 (en) | 2014-12-10 | 2020-06-25 | Amryt Endo, Inc. | Oral octreotide administered in combination with other therapeutic agents |
| US9957267B2 (en) | 2015-07-01 | 2018-05-01 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| EP3317278B1 (en) | 2015-07-01 | 2021-04-14 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| RS61645B1 (sr) | 2015-10-30 | 2021-04-29 | Neurocrine Biosciences Inc | Valbenazin ditozilat i njihovi polimorfi |
| EP3374350B1 (en) | 2015-11-09 | 2022-01-05 | Forge Therapeutics, Inc. | Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections |
| PT3889145T (pt) | 2015-12-17 | 2024-04-02 | Merck Patent Gmbh | 8-ciano-5-piperidino-quinolinas como antagonistas de tlr7/8 e suas utilizações para tratamento de distúrbios imunitários |
| MX2019000246A (es) | 2016-07-07 | 2019-05-27 | Plantex Ltd | Formas en estado solido del dimesilato de palbociclib. |
| IL264178B2 (en) | 2016-07-14 | 2024-05-01 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| EP3596062A4 (en) | 2017-03-16 | 2020-08-26 | Crinetics Pharmaceuticals, Inc. | SOMATOSTATIN MODULATORS AND THEIR USES |
| WO2018208987A2 (en) | 2017-05-10 | 2018-11-15 | Forge Therapeutics, Inc. | Antibacterial compounds |
| CN110913840A (zh) | 2017-08-11 | 2020-03-24 | 默克专利股份公司 | 包含3-氟-4-[7-甲氧基-3-甲基-8-(1-甲基-1H-吡唑-4-基)-2-氧代-2,3-二氢-咪唑并[4,5-c]喹啉-1-基]-苄腈的药物制剂 |
| PT3740475T (pt) | 2018-01-17 | 2022-07-18 | Crinetics Pharmaceuticals Inc | Processo de produção de moduladores da somatostatina |
| SMT202500155T1 (it) | 2018-09-18 | 2025-05-12 | Crinetics Pharmaceuticals Inc | Modulatori della somatostatina e loro usi |
| JP2022540922A (ja) * | 2019-07-17 | 2022-09-20 | クリネティックス ファーマシューティカルズ，インク． | ソマトスタチンモジュレーターの結晶形態 |
| CA3191084A1 (en) | 2020-09-09 | 2022-03-17 | Gerald Burke | Formulations of a somatostatin modulator |
| BR112023024465A2 (pt) | 2021-05-25 | 2024-02-06 | Crinetics Pharmaceuticals Inc | Usos de um modulador de somatostatina para o tratamento de doença |
| CN117377473A (zh) * | 2021-05-25 | 2024-01-09 | 克林提克斯医药股份有限公司 | 生长抑素调节剂用于治疗疾病的用途 |
-
2021
- 2021-09-07 CA CA3191084A patent/CA3191084A1/en active Pending
- 2021-09-07 EP EP21786673.0A patent/EP4210700B1/en active Active
- 2021-09-07 MD MDE20230709T patent/MD4210700T2/ro unknown
- 2021-09-07 DK DK21786673.0T patent/DK4210700T3/da active
- 2021-09-07 EP EP25185699.3A patent/EP4635497A3/en active Pending
- 2021-09-07 PL PL21786673.0T patent/PL4210700T3/pl unknown
- 2021-09-07 ES ES21786673T patent/ES3040117T3/es active Active
- 2021-09-07 SM SM20250315T patent/SMT202500315T1/it unknown
- 2021-09-07 CN CN202180068588.2A patent/CN116456968B/zh active Active
- 2021-09-07 FI FIEP21786673.0T patent/FI4210700T3/fi active
- 2021-09-07 SI SI202130344T patent/SI4210700T1/sl unknown
- 2021-09-07 RS RS20250820A patent/RS67208B1/sr unknown
- 2021-09-07 PE PE2023000942A patent/PE20231850A1/es unknown
- 2021-09-07 IL IL301038A patent/IL301038A/en unknown
- 2021-09-07 CN CN202610102122.4A patent/CN121943816A/zh active Pending
- 2021-09-07 KR KR1020237011002A patent/KR20230066379A/ko active Pending
- 2021-09-07 MA MA66139A patent/MA66139B1/fr unknown
- 2021-09-07 PT PT217866730T patent/PT4210700T/pt unknown
- 2021-09-07 LT LTEPPCT/US2021/049282T patent/LT4210700T/lt unknown
- 2021-09-07 MX MX2023002761A patent/MX2023002761A/es unknown
- 2021-09-07 AU AU2021341936A patent/AU2021341936A1/en active Pending
- 2021-09-07 US US17/468,440 patent/US11266641B1/en active Active
- 2021-09-07 HR HRP20250995TT patent/HRP20250995T1/hr unknown
- 2021-09-07 WO PCT/US2021/049282 patent/WO2022055880A1/en not_active Ceased
- 2021-09-07 JP JP2023515559A patent/JP7796115B2/ja active Active
- 2021-09-08 AR ARP210102492A patent/AR123453A1/es unknown
-
2022
- 2022-01-25 US US17/584,225 patent/US11957674B2/en active Active
-
2023
- 2023-03-01 ZA ZA2023/03250A patent/ZA202303250B/en unknown
- 2023-03-03 CL CL2023000627A patent/CL2023000627A1/es unknown
- 2023-04-04 CO CONC2023/0004346A patent/CO2023004346A2/es unknown
-
2024
- 2024-03-08 US US18/599,998 patent/US20240398782A1/en active Pending
-
2025
- 2025-12-19 JP JP2025269820A patent/JP2026067866A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540137A5 (https=) | ||
| TWI583384B (zh) | 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物 | |
| JP2005320354A5 (https=) | ||
| JP2017523206A5 (https=) | ||
| NO340156B1 (no) | Fremgangsmåte for fremstilling av en fast, oralt administrerbar farmasøytisk sammensetning | |
| JP2022548688A5 (https=) | ||
| JPH09143073A (ja) | 持続性ニフエジピン製剤 | |
| CN103550190A (zh) | 含有碱性药物或其盐的基质型缓释制剂 | |
| JP2022548687A5 (https=) | ||
| CN104114163A (zh) | 治疗心血管疾病的方法 | |
| HRP20250995T1 (hr) | Formulacije modulatora somatostatina | |
| CN103945831A (zh) | 医药制剂 | |
| JP2016188181A (ja) | ミラベグロン含有放出制御錠剤 | |
| JP2025172740A5 (https=) | ||
| JP2020511419A5 (https=) | ||
| TWI592154B (zh) | Allisartan-based solid dispersions and pharmaceutical compositions containing the solid dispersions | |
| US20070122480A1 (en) | Sustained release formulations | |
| JP6904955B2 (ja) | アプレミラスト徐放性製剤 | |
| JP2025505802A5 (https=) | ||
| US9820936B2 (en) | Oral controlled release pharmaceutical compositions of Bepotastine | |
| KR20070069105A (ko) | 서방성 제제 | |
| JP2017502062A5 (https=) | ||
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| US20140010883A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| JP2019513801A5 (https=) |